News in English

In this section You can read our columns, news and other articles that we publish in English. Once a year Life Science Sweden also publish an international issue of our printed magazine in English with an extended circulation in the Nordic countries.

“Don’t postpone the transition to IVDR”

To build trust, one must be able to say “I don’t know” – whether human or AI

KI’s new super machine measures brain activity in real-time – “A very expensive hairdo”

The Swedish Research Council gets go-ahead for more long-term funding
Ozempic may benefit hip replacement surgery
Raised millions to develop a treatment for ´butterfly children´
Rising interest in CRISPR treatments

Decades of research destroyed at KI – a hacker attack cannot be ruled out!

Anna Törner: “My quantified life”

Failed to read the fine print – lost his life’s work

Ingrid Lönnstedt: Demystification of the power of a scientific study
Study: Popular diabetes drug may be effective against liver disease
”Information security must become part of the Swedish life science strategy”
Suing the company – for NOT developing a new HIV drug
Unexpected study results on testosterone – no reduction in fracture risk
Acquisition of consulting company Key2Compliance
Major investment in women’s health – for a more equal healthcare system
A new special edition and a new event in Copenhagen – This is happening at Life Science Sweden 2024

Ingrid Lönnstedt: What does the p-value mean?

The International Vaccine Institute’s office in Sweden is expanding

Samuel Lagercrantz: We are currently seeing medical breakthroughs in these areas

Mathias Uhlén’s protein atlas is recognised as a global resource
Anna Törner: The clinical trial – Periscope to reality
A vaccine the world is waiting for: “It can change the lives of many”
Business Sweden: “Companies have a lot to offer in data-driven precision medicine”
The art of building a biologic drug
Novo Nordisk sues compounding pharmacies in the US
Study: Vaccination linked to lower risk of post-COVID
The Swedish innovation model: “There is a paradox”
Setback for Moderna in patent dispute with mRNA competitors
Eli Lilly to build a USD 2.5-billion plant in Germany
Novo Nordisk to invest billions in Danish manufacturing facilities
The Swedish Academy of Sciences: “We have too many researchers”
High biological age is linked to a higher risk of dementia and stroke
Tirzepatide approved for obesity by the FDA – to be branded as Zepbound
Founder of Bioarctic, Lars Lannfelt, is honoured: “I want to create something for the future”
“A major energy boost for the entire cancer vaccine field”
Ladda mer

Sänd till en kollega